2篇
您的检索式：作者名="Amrish Sahney"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 食管胃底静脉曲张的历史沿革、分类和分级显示文摘静脉曲张及其处理在门脉高压的治疗中极为重要。对于门脉高压中静脉曲张的处理,目前的各种指南都趋于统一。然而,静脉曲张的分类和分级在世界各地却各不相同。本文重点讨论了静脉曲张分类和分级系统的历史沿革和应用现状,并辅以自制的图表,力图令读者对门脉高压和静脉曲张有一个更加深入且清晰的认识。 | Cyriac Abby Philips Amrish Sahney | 2016 | Gastroenterology Report2016，4，3： | 1 |
| 2 | Impact of Living Donor Liver Transplantation on COVID-19 Clinical Outcomes from a Quaternary Care Centre in Delhi显示文摘Background and Aims:The anticipated fear of serious out-comes in coronavirus infected liver transplant recipients led to disruption of transplant services globally.The aim of our study was to analyze COVID-19 severity in transplant recipients and to compare the difference of COVID-19 clinical outcomes in early(<1 year)vs.late(>1 year)post-transplant period.Methods:41 post-living donor liver transplant recipients with COVID-19 infection were studied retrospectively from 1st April 2020 to 28th February 2021.Results:The median age was 49.00 years with a male preponderance(80.49%).Fif-teen patients had infection within 1 year of transplant and 26 were infected after 1 year of transplant.The overall median interval between transplantation and COVID-19 diagnosis was 816.00 days.Fever and malaise were the common presenting symptoms.The most common associated comorbidities were diabetes mellitus(65.85%)and hypertension(46.34%).The severity of illness was mild in 28(68.29%),moderate in 4(9.76%),severe in 6(14.63%)and critical in 3(7.32%).To identify associated risk factors,we divided our patients into less severe and more severe groups.Except for lymphopenia,there was no worsening of total bilirubin,transaminases,al-kaline phosphatase,and gamma-glutamyl transferase in the more severe group.Eight(19.51%)patients required inten-sive care unit admission and three(7.32%)died,while none suffered graft rejection.In recipients with early vs.late post-transplant COVID-19 infection,there were similar outcomes in terms of severity of COVID-19 illness,intensive care unit care need,requirement of respiratory support,and death.Conclusion:Living donor liver transplantation can be per-formed during the COVID-19 pandemic without the fear of poor recipient outcome in cases of unfortunate contraction of severe acute respiratory syndrome coronavirus-2. | Imtiakum Jamir Niteen Kumar Gaurav Sood Ashish George Pankaj Lohia Samba Siva Rao Pasupuleti Amrish Sahney Manav Wadhawan Ajay Kumar Abhideep Chaudhary | 2022 | Journal of Clinical and Translational Hepatology2022，10，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员